BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.46B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$887M |
| 4 |
Apple
AAPL
|
+$609M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$582M |
Top Sells
| 1 |
Pfizer
PFE
|
+$104M |
| 2 |
Visa
V
|
+$92M |
| 3 |
iShares US Financials ETF
IYF
|
+$83.8M |
| 4 |
Charter Communications
CHTR
|
+$65.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$53.4M |
Sector Composition
| 1 | Technology | 15.84% |
| 2 | Healthcare | 9.89% |
| 3 | Financials | 8.48% |
| 4 | Consumer Discretionary | 7.47% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Teekay
TK
$722M
| $67.6K | ﹤0.01% |
21,408
+4,643
| +28% | +$14.7K |
|
|
LAND
2652
Gladstone Land Corp
LAND
$321M
| $67.4K | ﹤0.01% |
5,691
+1,260
| +28% | +$14.9K |
|
|
CHUY
2653
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $67K | ﹤0.01% |
6,653
+1,157
| +21% | +$11.7K |
|
2654
Precision BioSciences
DTIL
$54.3M
| $66.9K | ﹤0.01% |
370
+231
| +166% | +$41.8K |
|
2655
UNIFI
UFI
$82.8M
| $66.8K | ﹤0.01% |
5,784
+659
| +13% | +$7.61K |
|
|
OLP
2656
One Liberty Properties
OLP
$494M
| $66.8K | ﹤0.01% |
4,793
+925
| +24% | +$12.9K |
|
2657
Willdan Group
WLDN
$1.48B
| $66.7K | ﹤0.01% |
3,121
+1,640
| +111% | +$35K |
|
2658
Scholar Rock
SRRK
$3.04B
| $66.1K | ﹤0.01% |
5,458
+3,378
| +162% | +$40.9K |
|
2659
Global Indemnity Group
GBLI
$428M
| $66K | ﹤0.01% |
2,590
+681
| +36% | +$17.4K |
|
2660
NWPX Infrastructure, Inc. Common Stock
NWPX
$495M
| $65.9K | ﹤0.01% |
2,960
+653
| +28% | +$14.5K |
|
2661
MannKind Corp
MNKD
$1.71B
| $65.8K | ﹤0.01% |
63,839
+41,316
| +183% | +$42.6K |
|
2662
Wave Life Sciences
WVE
$1.11B
| $65.5K | ﹤0.01% |
6,989
+4,336
| +163% | +$40.6K |
|
|
HMHC
2663
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $65.2K | ﹤0.01% |
34,664
-275
| -0.8% | -$517 |
|
2664
Vishay Precision Group
VPG
$416M
| $65.1K | ﹤0.01% |
3,243
+1,400
| +76% | +$28.1K |
|
2665
Ocular Therapeutix
OCUL
$2.23B
| $65.1K | ﹤0.01% |
13,149
+6,803
| +107% | +$33.7K |
|
|
CNR
2666
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $65K | ﹤0.01% |
14,251
+2,857
| +25% | +$13K |
|
2667
Mersana Therapeutics
MRSN
$35.6M
| $64.8K | ﹤0.01% |
445
+99
| +29% | +$14.4K |
|
|
RVI
2668
DELISTED
Retail Value Inc. Common Shares
RVI
| $64.3K | ﹤0.01% |
57,217
+16,167
| +39% | +$18.2K |
|
2669
Carter Bankshares
CARE
$450M
| $64K | ﹤0.01% |
6,970
+1,468
| +27% | +$13.5K |
|
|
WPG
2670
DELISTED
Washington Prime Group Inc.
WPG
| $63.6K | ﹤0.01% |
8,780
-743
| -8% | -$5.38K |
|
|
ORC
2671
Orchid Island Capital
ORC
$1.04B
| $63.5K | ﹤0.01% |
4,305
+1,720
| +67% | +$25.4K |
|
2672
National Bankshares
NKSH
$192M
| $63.4K | ﹤0.01% |
1,988
+420
| +27% | +$13.4K |
|
2673
Regis Corp
RGS
$70.8M
| $63.4K | ﹤0.01% |
536
-3
| -0.6% | -$355 |
|
|
SYRS
2674
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $63.4K | ﹤0.01% |
1,069
+668
| +167% | +$39.6K |
|
2675
KRONOS Worldwide
KRO
$694M
| $63.3K | ﹤0.01% |
7,496
+1,496
| +25% | +$12.6K |
|